|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mathé EA, Nguyen GH, Bowman ED, Zhao Y,
Budhu A, Schetter AJ, Braun R, Reimers M, Kumamoto K, Hughes D, et
al: MicroRNA expression in squamous cell carcinoma and
adenocarcinoma of the esophagus: Associations with survival. Clin
Cancer Res. 15:6192–6200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tepper J, Krasna MJ, Niedzwiecki D, Hollis
D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D and Mayer
R: Phase III trial of trimodality therapy with cisplatin,
fluorouracil, radio-therapy, and surgery compared with surgery
alone for esophageal cancer: CALGB 9781. J Clin Oncol.
26:1086–1092. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yi S and Tsao MS: Activation of hepatocyte
growth factor-met autocrine loop enhances tumorigenicity in a human
lung adenocarcinoma cell line. Neoplasia. 2:226–234. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carneiro F and Sobrinho-Simoes M: The
prognostic significance of amplification and overexpression of
c-met and c-erb B-2 in human gastric carcinomas. Cancer.
88:238–240. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brady HJ and Gil-Gómez G: Bax. The
pro-apoptotic Bcl-2 family member, Bax. Inter J Biochem Cell Biol.
30:647–650. 1998. View Article : Google Scholar
|
|
7
|
Lu QL, Abel P, Foster CS and Lalani EN:
bcl-2: Role in epithelial differentiation and oncogenesis. Hum
Pathol. 27:102–110. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen K, Hu Z, Wang LE, Sturgis EM,
El-Naggar AK, Zhang W and Wei Q: Single-nucleotide polymorphisms at
the TP53-binding or responsive promoter regions of BAX and BCL2
genes and risk of squamous cell carcinoma of the head and neck.
Carcinogenesis. 28:2008–2012. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Young RL and Korsmeyer SJ: A negative
regulatory element in the bcl-2 5′-untranslated region inhibits
expression from an upstream promoter. Mol Cell Biol. 13:3686–3697.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaderi MA, Norberg M, Murray F, Merup M,
Sundström C, Roos G, Aleskog A, Karlsson K, Axelsson T, Tobin G and
Rosenquist R: The BCL-2 promoter (−938C>A) polymorphism does not
predict clinical outcome in chronic lymphocytic leukemia. Leukemia.
22:339–343. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kidd LR, Coulibaly A, Templeton TM, Chen
W, Long LO, Mason T, Bonilla C, Akereyeni F, Freeman V, Isaacs W,
et al: Germline BCL-2 sequence variants and inherited
predisposition to prostate cancer. Prostate Cancer Prostatic Dis.
9:284–292. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Parkin DM, Bray FI and Devesa SS:
Corrigendum to ‘Cancer burden in the year 2000. The global
picture’. Eur J Cancer. 37 Suppl 8:S4–S66. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang SW, Zhang M and Li GL: An analysis
of incidence and mortality of esophageal cancer in China,
2003–2007. China Cancer. 4:241–247. 2012.
|
|
14
|
Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y,
Ueda J, Wei W, Inoue M and Tanaka H: Epidemiology of esophageal
cancer in Japan and China. J Epidemiol. 23:233–242. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang T and Hou P: Research progress on
etiology of esophageal cancer. Sichuan J Anat. 3:28–30. 2015.
|
|
16
|
Sarbia M, Bittinger F, Grabellus F,
Verreet P, Dutkowski P, Willers R and Gabbert HE: Expression of
Bax, a pro-apoptotic member of the Bc-l 2 family, in esophageal
squamous cell carcinoma. Int J Cancer. 73:508–513. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ogura E, Senzaki H, Yamamoto D, Yoshida R,
Takada H, Hioki K and Tsubura A: Prognostic significance of Bcl-2,
Bcl-xL/S, Bax and Bak expressions in colorectal carcinomas. Oncol
Rep. 6:365–369. 1999.PubMed/NCBI
|
|
18
|
Schelwies K, Sturm I, Grabowski P,
Scherübl H, Schindler I, Hermann S, Stein H, Buhr HJ, Riecken EO,
Zeitz M, et al: Analysis of p53/BAX in primary colorectal
carcinoma: Low BAX protein expression is a negative prognostic
factor in UICC stage III tumors. Int J Cancer. 99:589–596. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Russo A, Maiolino S, Pagliara V, Ungaro F,
Tatangelo F, Leone A, Scalia G, Budillon A, Quaglia F and Russo G:
Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in
p53 null colon cancer cells through combined polymer nanoparticles.
Oncotarget. 7:79670–79687. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Katkoori VR, Suarez-Cuervo C, Shanmugam C,
Jhala NC, Callens T, Messiaen L, Posey J III, Bumpers HL, Meleth S,
Grizzle WE and Manne U: Bax expression is a candidate prognostic
and predictive marker of colorectal cancer. J Gastrointest Oncol.
1:76–89. 2010.PubMed/NCBI
|
|
21
|
Wang DG, Fan JB, Siao CJ, Berno A, Young
P, Sapolsky R, Ghandour G, Perkins N, Winchester E, Spencer J, et
al: Large-scale identification, mapping and genotyping of
single-nucleotide polymorphisms in the human genome. Science.
280:1077–1082. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
He M, Chen MH, Xie HZ, Yao SZ, Zhu B, Feng
LP and Wu YP: Transvaginal removal of ectopic pregnancy tissue and
repair of uterine defect for caesarean scar pregnancy. BJOG.
118:1676–1677. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li N, Zhu F, Fu S and Shi X: Transvaginal
ultrasound-guided embryo aspiration plus local administration of
low-dose methotrexate for caesarean scar pregnancy. Ultrasound Med
Biol. 38:209–213. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Coniglio C and Dickinson JE: Pregnancy
following prior Caesarean scar pregnancy rupture: Lessons for
modern obstetric practice. Aust N Z J Obstet Gynaecol. 44:162–165.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yao Q, Chen J, Lv Y, Wang T, Zhang J, Fan
J and Wang L: The significance of expression of autophagy-related
gene Beclin, Bcl-2, and Bax in breast cancer tissues. Tumour Biol.
32:1163–1171. 2011. View Article : Google Scholar : PubMed/NCBI
|
